Primary immunodeficiency syndrome represents a group of inherited conditions that affect how the immune system works, making it harder for the body to protect itself against infections and other threats. Understanding when and how to test for these conditions can make a life-changing difference in getting the right care early.

Introduction: Who Should Undergo Diagnostics and When

Diagnosing primary immunodeficiency is not always straightforward, and knowing when to seek testing is crucial for protecting your health or your child’s health. If you notice that you or your child is getting sick much more often than others around you, this might be a sign that something needs attention. The infections may not just be frequent, but they may also last longer, be harder to treat, or keep coming back even after antibiotics have been prescribed.^[1]

You should consider seeking diagnostics if infections require unusually long courses of antibiotics or if they need intravenous treatment to clear up. Infections that are severe enough to require hospitalization, such as sepsis (a life-threatening response to infection) or internal organ abscesses, are red flags that warrant investigation. Additionally, if you or your child experiences infections from organisms that most people don’t get, known as opportunistic infections, this could indicate a compromised immune system.^[4]

Sometimes primary immunodeficiency shows itself through other symptoms beyond infections. Poor growth or failure to gain weight in infants, ongoing digestive problems like chronic diarrhea, swollen lymph nodes or an enlarged spleen, and recurring skin abscesses can all be warning signs. If your family has a history of primary immunodeficiency, it becomes even more important to discuss testing with your healthcare provider, as these conditions often run in families due to their genetic nature.^[2]

Early diagnosis is essential because it can prevent or delay serious health problems that primary immunodeficiency can cause. Left untreated, some types can result in permanent organ damage or even death. With prompt diagnosis and appropriate treatment, many people with primary immunodeficiency can lead active and fulfilling lives.^[4]

Classic Diagnostic Methods Used to Identify Primary Immunodeficiency

When a doctor suspects primary immunodeficiency, the diagnostic journey usually begins with a thorough review of your medical history. Your healthcare provider will want to know about the frequency, severity, and types of infections you’ve experienced. They will also ask whether any close relatives have been diagnosed with an inherited immune system disorder, since these conditions often have a genetic component that runs in families.^[10]

A physical examination is an important next step. The doctor will look for physical signs that might suggest immune system problems, such as swollen lymph nodes, an enlarged spleen or liver, or signs of chronic infection. However, because primary immunodeficiency can have many different forms and presentations, laboratory tests are essential to confirm a diagnosis and understand which part of the immune system is affected.^[11]

Blood Tests: The Foundation of Diagnosis

Blood tests form the backbone of diagnostic testing for primary immunodeficiency. A complete blood count is typically one of the first tests ordered. This test measures the levels of different types of blood cells and immune system cells circulating in your body. When the numbers of certain cells fall outside the normal range, it can indicate that something is wrong with how the immune system is developing or functioning.^[8]

Measuring levels of immunoglobulins, which are infection-fighting proteins also known as antibodies, is another critical blood test. The three most important types that doctors check are IgG, IgA, and IgM. People with primary immunodeficiency often have abnormally low levels of one or more of these immunoglobulins, which makes it harder for their bodies to fight off infections. Some people may also need testing for IgG subclasses, which are different varieties of the IgG antibody that each play specific roles in immune defense.^[6]

Beyond measuring the quantity of antibodies, doctors also need to know if those antibodies actually work properly. To assess this, they check your antibody response to vaccines you’ve received in the past. This means they measure whether your immune system created specific antibodies after immunizations for diseases like tetanus, diphtheria, or pneumococcal infections. If your body didn’t produce adequate antibodies in response to these vaccines, it suggests your B-cell function—the part of the immune system that makes antibodies—is impaired.^[8]

Tests for Different Parts of the Immune System

Because the immune system has many different components, testing must be tailored to evaluate each one. For T-cell function, doctors may use skin tests for delayed-type hypersensitivity (a type of immune reaction), or they may test how your T-cells respond to certain stimulating substances in the laboratory. They can also measure the production of cytokines, which are signaling molecules that T-cells use to communicate with other immune cells.^[8]

If problems with infection-fighting white blood cells called phagocytes are suspected, specialized tests can evaluate how well these cells move toward bacteria and whether they can effectively kill the germs they encounter. One common test involves measuring the reduction of a chemical called nitro blue tetrazolium chloride, which changes color when phagocytes are working properly. Other tests assess the movement and bactericidal activity of these cells.^[8]

The complement system, which is a group of proteins in the blood that helps antibodies and phagocytes clear pathogens from the body, can also be evaluated through blood tests. Complement deficiencies can make people more susceptible to certain types of infections, so testing this system is important when primary immunodeficiency is suspected.^[6]

Advanced Testing Methods

More sophisticated tests include flow cytometry, a laboratory technique that can identify and count different types of immune cells in the blood based on markers on their surface. This helps doctors determine whether you have the right mix of different immune cell types, including various groups of T-cells, B-cells, natural killer cells, and monocytes. It can also detect whether these cells show signs of activation, which provides clues about ongoing immune responses.^[8]

Lymphocyte proliferation assays measure how well your immune cells multiply in response to stimulation. In a healthy immune system, certain cells should divide rapidly when exposed to foreign substances or specific chemicals. If your cells don’t proliferate as expected, it indicates a functional problem with your immune system.^[6]

Genetic Testing and Newborn Screening

Genetic testing has become increasingly important in diagnosing primary immunodeficiency because most of these conditions are caused by changes in specific genes. DNA testing can identify the exact genetic variant responsible for the immune deficiency, which helps doctors predict how the disease might progress and determine the most appropriate treatment. For families with a known history of primary immunodeficiency, genetic testing can be done during pregnancy to prepare for treatment if needed.^[10]

All states in the United States now include testing for one severe form of primary immunodeficiency called severe combined immunodeficiency (SCID) as part of routine newborn screening. This early detection is crucial because SCID is life-threatening but can be treated successfully if caught immediately after birth, before the baby has received live vaccines or been exposed to serious infections.^[4]

Diagnostics for Clinical Trial Qualification

When patients with primary immunodeficiency are being considered for enrollment in clinical trials, they typically undergo the same foundational diagnostic tests used for standard diagnosis, but the requirements may be more stringent and detailed. Clinical trials often require specific documentation of the exact type of primary immunodeficiency, the severity of the condition, and how it affects various components of the immune system.^[6]

Researchers conducting clinical trials need to ensure that participants meet precise criteria so that the results of the study will be meaningful and applicable to others with the same condition. This means that comprehensive blood testing to measure immunoglobulin levels, including IgG, IgA, IgM, and sometimes IgG subclasses, is standard. Detailed lymphocyte counts and flow cytometry to identify specific immune cell populations are often required to characterize exactly which parts of the immune system are affected.^[8]

Clinical trials may also require genetic confirmation of the diagnosis through DNA sequencing. Knowing the exact genetic mutation can be essential for trials testing treatments designed to correct specific genetic defects or for trials evaluating therapies targeted at particular types of primary immunodeficiency. For instance, trials testing gene therapy approaches need to confirm that participants have the specific genetic variant that the therapy is designed to correct.^[12]

Documentation of infection history is another important component of qualification for clinical trials. Researchers typically want detailed records of past infections, including their frequency, severity, which organisms caused them, and how they responded to treatment. This information helps establish baseline disease activity and allows researchers to measure whether the experimental treatment being studied reduces infection rates or improves immune function.^[11]

Some clinical trials may require baseline assessments of organ function, especially for trials testing treatments with potential side effects on specific organs. Blood tests to check liver and kidney function, imaging studies to look at organ structure, and tests to evaluate heart or lung function might all be part of the screening process. These tests help ensure that participants can safely receive the experimental treatment and allow researchers to monitor for any adverse effects during the trial.^[11]

For trials evaluating hematopoietic stem cell transplantation (bone marrow transplant) or gene therapy approaches, additional specialized testing is required. This includes tissue typing to match donors and recipients, tests to evaluate bone marrow function, and assessments to determine whether the patient is healthy enough to undergo these intensive procedures. The screening process for such trials is particularly thorough because these treatments carry significant risks alongside their potential benefits.^[14]